Níveis plasmáticos de ácidos graxos e fosfolipase A 2 em crianças com autismo Fatty acid and phospholipase A 2 plasma levels in children with autism Abstract Objective: To evaluate fatty acid plasma levels, phospholipase A 2 activity, and the developmental profiles of children with autism vs. control subjects. Methods: Twenty four children with autism underwent laboratory analysis for fatty acid quantification using gas chromatography and PLA 2 activity determination by fluorometric assay. Results: No correlation was observed between the developmental quotient and fatty acid plasma levels. Phospholipase A 2 activity was significantly higher among autistic children compared with controls.
Introduction
Reduced levels of polyunsaturated fatty acids have been associated with some childhood mental disorders such as attention deficit hyperactivity disorder (ADHD) in boys, 1, 2 severe deficits in reading, spelling, and auditory memory, 3 as well as dyslexia and developmental coordination disorder (DCD). 4 Autism spectrum disorders (ASD) also seem to be associated with altered lipid metabolism in their pathogenesis.
These alterations provoke changes in the structure and function of cell membrane phospholipids, similarly to what is observed in other developmental disorders. 5, 6 A significant reduction in the levels of polyunsaturated fatty acids in the red blood cell membrane of patients with autism reinforces this assumption. 5, 7 Recently, El-Ansary et al. 8 evaluated fatty acid profile in the plasma of 26 autistic children and 26 age-matched healthy children. The authors found increased levels of most saturated fatty acids, except for propionic acid, and reduced levels of most polyunsaturated fatty acids. Moreover, omega-3 supplementation in children with ASD appears to be safe and effective in improving behavior. 9 Also, children with ASD have been shown to present significantly higher phospholipase A 2 (PLA 2 ) activity. 7 In fact, evidence suggests that the instability observed in fatty acid levels may be caused by an increase in PLA 2 activity, perhaps in association with the high oxidative stress found in these patients. 10 In this context, the objective of this study was to evaluate fatty acid plasma levels, PLA 2 activity, and the developmental profiles of children with autism compared with control subjects.
Methods

Patients
The study included children with autism and Additional interviews were conducted whenever necessary to complete these steps.
Neuropsychological assessment was performed using the Psychoeducational Profile -Revised (PEP-R), an instrument created to assess developmental age in children with autism. minutes at room temperature, and then stored in a freezer at -70 ºC until laboratory analysis. All materials were coded to preserve patient anonymity, and all procedures followed the principles of good laboratory practice.
Fatty acid quantification
Fatty acid levels were determined according to the method originally described by Folch et al. 15 and modified by El-Ansary et al. 8 Briefly Serum blank reactions were stopped at zero time.
Statistical analysis
Results were analyzed using descriptive statistics.
Correlations between parameters were assessed using Pearson's correlation coefficient. Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS) version 13.0 for Windows.
Results
Patients
Mean age in the group of autistic patients (n = 24) was 7.4±2.9 years, and in the control group (n = 24), 7.2±1.8 years (age range in both groups: 2-12 years). A total of 18 children were male in each of the groups (boy to girl ratio = 3:1).
In the week preceding blood collection, none of children had started the use of any new medication. Of the 24 autistic children, 21 (87.5%) were making use of psychotropic drugs to treat autism symptoms, under either monotherapy (n = 7) or polytherapy (n = 14).
The drugs most frequently prescribed were risperidone and carbamazepine, used in combination with each other or with other drugs. Control children were not on any medication. None of the children in any group were using supplements containing omega-3 and/or omega-6.
In the patient group, nine children (37.5%) had a history of seizures during development. In the control group, none of the children reported the occurrence of seizures.
Application of the PEP-R scale of development yielded a total score based on the sum of points in the "Passed" category (1 point for each item in that category). 
Fatty acid quantification
ARA plasma levels (weight percentage of total fatty acids) were significantly elevated in autistic children , n = 24) (p < 0.05).
Discussion
The demographic characteristics of our sample, with a larger share of male children, at a 3:1 ratio, corroborate the already known higher incidence of autism in boys, with ratios ranging from 3.5 to 4 boys for every girl. 17 Even though this ratio may vary depending on the degree of intellectual function, among the six girls with autism in our study, one had a developmental age of 34, and all others, < 18. Among the girls in the control group, one showed a developmental age of 73, compared to 77 for all the others (data not shown). When autistic children were divided according to QD, four girls and seven boys were included in the subgroup with more severe developmental deficits (QD < 15). The subgroup with higher QD (> 15), in turn, included two girls and 11 boys. These data suggest a change in sex ratio, with a greater representation of women, especially when considering children with larger deficits in learning patterns, as indicated by Klin 17 and by Mercadante & Rosário. 18 According to Aman et al., 19 it is estimated that 46% of children with global development disorders are treated with psychotropic drugs to control symptoms. In our study, of the 24 children in the case group, 21 (87.5%) were using psychotropic drugs, and 14 children were using two or more psychotropic drugs to reduce symptoms associated with the autistic spectrum. Even though we have included solely children with autism and no other ASD, the frequency of prescriptions seems high and could be related to a poor implementation of health care routines, combined with a scarcity of specialized care in Brazil. 20 With regard to fatty acid quantification results, high plasma levels of ARA and low levels of EPA and DHA were observed in the group of autistic children, which is consistent with the evidence of altered lipid metabolism in neuropsychiatric disorders. It has been proposed that such imbalance is related to changes in the structure and function of cell membrane phospholipids. 5 In particular, the levels of EPA have been associated with the production of eicosanoids, which have anti-inflammatory, antithrombotic, and vasodilator properties 8 and were reduced in the autistic children of our study. DHA has a role in inhibiting neuronal apoptosis and regulating neuronal excitability, 22 and it may also modulate abnormal electrical impulses in the neurons. 23 A deficit of these fatty acids could be related to the increased susceptibility to seizures observed in patients with ASD and was observed in our group of autistic children.
Our results are consistent with those reported by Bell et al. 24 Those authors also found an increase in ARA:EPA ratio in erythrocytes and plasma of autistic children vs. age-matched children with normal development.
However, our findings are discordant with those of El-Ansary et al., 25 who observed reduced ARA:DHA and higher EPA:ARA ratios in autistic patients. These differences can probably be explained by fluctuations in EPA and DHA levels as a result of different dietary patterns, as the levels of ARA remain relatively stable.
Omega-3 supplementation has been associated with better results in behavioral assessment scales applied to autistic children. 9 In addition, patients who receive EPA supplementation have been shown to present a reduced PLA 2 activity when compared with patients not supplemented. 7 These findings confirm that the children participating in our study were not using any dietary supplement.
The high levels of PLA 2 activity observed in our autistic children are consistent with the report of Bell et al. In sum, autistic children show abnormalities in phospholipid metabolism and developmental profile.
However, the present study did not show a correlation between fatty acid and phospholipase A 2 plasma levels and the developmental profile of children with autism.
